HF743 (Legislative Session 94 (2025-2026))
Use of step therapy protocol prohibited for insulin drugs.
Related bill: SF2071
AI Generated Summary
This bill, introduced in the Minnesota House of Representatives, aims to prohibit health insurance plans from using a step therapy protocol for insulin prescriptions. Step therapy is a practice where patients are required to try one or more cheaper or preferred medications before the insurer will cover the originally prescribed medication. The bill specifically targets insulin drugs used in the treatment of all types of diabetes, including Type I, Type II, and gestational diabetes. If passed, this legislation would ensure that patients with diabetes can access the insulin prescribed by their healthcare providers without having to first try and possibly fail on other medications.
Bill text versions
- Introduction PDF file
Actions
Date | Chamber | Where | Type | Name | Committee Name |
---|---|---|---|---|---|
February 12, 2025 | House | Floor | Action | Introduction and first reading, referred to | Commerce Finance and Policy |
Citations
[ { "analysis": { "added": [ "New provisions relating to the prohibition of step therapy for insulin drugs." ], "removed": [], "summary": "Relates to amending the Minnesota health insurance statute regarding the use of step therapy protocols.", "modified": [ "Amendment to clarify coverage requirements for insulin drugs specifically in the context of existing protocols." ] }, "citation": "256B.0625, subdivision 13f" } ]